Literature DB >> 15124237

Whither the ACR20?

David T Felson.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15124237

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  4 in total

1.  Therapy: what should we do after the failure of a first anti-TNF?

Authors:  Chris Deighton
Journal:  Nat Rev Rheumatol       Date:  2009-11       Impact factor: 20.543

2.  A model of impairment and functional limitation in rheumatoid arthritis.

Authors:  Agustín Escalante; Roy W Haas; Inmaculada del Rincón
Journal:  BMC Musculoskelet Disord       Date:  2005-03-15       Impact factor: 2.362

3.  Improving the power of clinical trials of rheumatoid arthritis by using data on continuous scales when analysing response rates: an application of the augmented binary method.

Authors:  James M S Wason; Martin Jenkins
Journal:  Rheumatology (Oxford)       Date:  2016-06-23       Impact factor: 7.580

Review 4.  Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.

Authors:  Josef S Smolen; Sabine Collaud Basset; Maarten Boers; Ferdinand Breedveld; Christopher J Edwards; Tore K Kvien; Pierre Miossec; Tuulikki Sokka-Isler; Ronald F van Vollenhoven; Eric C Abadie; Olivier Bruyère; Cyrus Cooper; Heidi Mäkinen; Thierry Thomas; Peter Tugwell; Jean-Yves Reginster
Journal:  Ann Rheum Dis       Date:  2016-04-01       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.